EPA Past President, Prof. Geert Dom, spoke at the event on the Future of the Younger Generation: How to Curb the Addiction Epidemic and Protect Europe’s Brain Capital at the European Parliament in Brussels at the Conference on 24 June…
The Gaining Experience Programme is an EPA initiative, meant to send talented Early-Career Psychiatrists (ECPs) from across Europe on an observership in another country. The objective is to make them engage in enriching opportunities to advance their expertise and contribute…
The EPA is deeply saddened by the passing of Professor Jules Angst on 15 May 2026. He was a brilliant psychiatrist appreciated and admired for his dedication, his constant curiosity and his encyclopedic knowledge on a wide variety of subjects….
The EPA submitted a response to the European Commission Consultation on Cardiovascular Health Checks, calling for people with severe mental illness to be explicitly recognised as a high risk population in screening programmes for cardiovascular health. People with severe mental…
The EPA was pleased to join the event on Psychedelic Research and Access in Ukraine at the European Parliament in Brussels. The event was organised by our partners at PAREA and the the MEP Action Group on Psychedelics in Healthcare,…
The EPA had the opportunity to create an editorial for Open Access Government, on the subject of “Towards trauma-informed, integrated care for young people in Europe”. Prof. Andrea Fiorillo, EPA President, discussed the growing mental health crisis among young people…
EPA President-Elect Prof. Celso Arango was interviewed on the BBC Radio 4PM programme, produced by BBC News, on how people who are night owls might have higher risk of anxiety, depression and bipolar disorder. Listen to the interview here. Read…
Registration for the European Board Examination is now open, offering psychiatrists a unique opportunity to demonstrate their knowledge and gain recognition at a European level! The EBEP is a fully online, knowledge-based exam taking place on Friday 25 September 2026….
PsyPal, the first consortium to receive an EU clinical research grant for the study of psychedelic therapy, has published a comprehensive guidance paper to inform stakeholders across research, clinical practice, regulation, policy, advocacy, and industry. The paper outlines key considerations…
The 2026 edition is co-developed by Ambassadors of the European Psychiatric Association (EPA) and European Society of Cardiology (ESC). The survey for mental health and cardiovascular health specialists was launched at the EPA-ESC Joint Symposium in Prague on Sunday, 29…